81_FR_77163 81 FR 76949 - Withdrawal of 60-Day Notice of Proposed Information Collection: Unaccompanied Children Case Summary Form

81 FR 76949 - Withdrawal of 60-Day Notice of Proposed Information Collection: Unaccompanied Children Case Summary Form

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families

Federal Register Volume 81, Issue 214 (November 4, 2016)

Page Range76949-76949
FR Document2016-26686

On October 4, 2016 at 81 FR 68420, ACF published a 60 Day Notice of Proposed Information Collection entitled ``Unaccompanied Children Case Summary Form.'' ACF is withdrawing this notice from the Federal Register.

Federal Register, Volume 81 Issue 214 (Friday, November 4, 2016)
[Federal Register Volume 81, Number 214 (Friday, November 4, 2016)]
[Notices]
[Page 76949]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-26686]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Children and Families


Withdrawal of 60-Day Notice of Proposed Information Collection: 
Unaccompanied Children Case Summary Form

AGENCY: Administration for Children and Families, HHS.

ACTION: Withdrawal: Notice.

-----------------------------------------------------------------------

SUMMARY: On October 4, 2016 at 81 FR 68420, ACF published a 60 Day 
Notice of Proposed Information Collection entitled ``Unaccompanied 
Children Case Summary Form.'' ACF is withdrawing this notice from the 
Federal Register.

FOR FURTHER INFORMATION CONTACT: Robert Sargis, Reports Clearance 
Officer, Office of Planning Research and Evaluation.

Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2016-26686 Filed 11-3-16; 8:45 am]
 BILLING CODE 4184-01-P



                                                                                           Federal Register / Vol. 81, No. 214 / Friday, November 4, 2016 / Notices                                                                                    76949

                                                    Tribes and Tribal organizations must                                        collection activity is set to expire in                                       Respondents: Tribes and Tribal
                                                    respond if they wish to operate a fully                                     December, 2016.                                                             Organizations.
                                                    funded program. This paperwork

                                                                                                                                         ANNUAL BURDEN ESTIMATES
                                                                                                                                                                                                          Number of                  Average
                                                                                                                                                                               Number of                                                              Total
                                                                                                      Instrument                                                                                        responses per              burden hours
                                                                                                                                                                              respondents                                                         burden hours
                                                                                                                                                                                                          respondent               per response

                                                    45 CFR 309 Amended Plan ............................................................................                                         63                          1              120          7,560
                                                    45 CFR 309 New Plan ....................................................................................                                      2                          1              480            960

                                                          Total ..........................................................................................................   ........................   ........................            600          8,520

                                                                Estimated Total Annual Burden Hours ..............................................                           ........................   ........................            600          8,520



                                                      Additional Information: Copies of the                                     Summary Form.’’ ACF is withdrawing                                          development research collaborations,
                                                    proposed collection may be obtained by                                      this notice from the Federal Register.                                      and copies of the U.S. patent
                                                    writing to the Administration for                                           FOR FURTHER INFORMATION CONTACT:                                            applications listed below may be
                                                    Children and Families, Office of                                            Robert Sargis, Reports Clearance Officer,                                   obtained by contacting: Attn: Sury Vepa,
                                                    Planning, Research and Evaluation, 330                                      Office of Planning Research and                                             Ph.D., J.D., Senior Licensing and
                                                    C Street SW., Washington, DC 20201.                                         Evaluation.                                                                 Patenting Manager, National Center for
                                                    Attention Reports Clearance Officer. All                                                                                                                Advancing Translational Sciences, NIH,
                                                                                                                                Robert Sargis,
                                                    requests should be identified by the title                                                                                                              9800 Medical Center Drive, Rockville,
                                                    of the information collection. Email                                        Reports Clearance Officer.                                                  MD 20850, Phone: 301–217–9197, Fax:
                                                    address: infocollection@acf.hhs.gov.                                        [FR Doc. 2016–26686 Filed 11–3–16; 8:45 am]                                 301–217–5736, or email
                                                      OMB Comment: OMB is required to                                           BILLING CODE 4184–01–P                                                      NCATSPartnerships@mail.nih.gov. A
                                                    make a decision concerning the                                                                                                                          signed Confidential Disclosure
                                                    collection of information between 30                                                                                                                    Agreement may be required to receive
                                                                                                                                DEPARTMENT OF HEALTH AND                                                    copies of the patent applications.
                                                    and 60 days after publication of this                                       HUMAN SERVICES
                                                    document in the Federal Register.                                                                                                                       SUPPLEMENTARY INFORMATION:      As per the
                                                    Therefore, a comment is best assured of                                     National Institutes of Health                                               Anxiety and Depression Association of
                                                    having its full effect if OMB receives it                                                                                                               America, Major depressive disorder
                                                    within 30 days of publication. Written                                      National Institute of Aging (NIA),                                          affects 14.8 million people in America,
                                                    comments and recommendations for the                                        National Institute of Mental Health                                         including children, adults, and the
                                                    proposed information collection should                                      (NIMH), and National Center for                                             elderly. A number of therapies currently
                                                    be sent directly to the following: Office                                   Advancing Translational Sciences                                            exist to treat depression, although they
                                                    of Management and Budget, Paperwork                                         (NCATS): Cooperative Research and                                           suffer drawbacks such as requiring
                                                    Reduction Project, Email: OIRA_                                             Development Agreement (CRADA) and                                           weeks to take action. One particular
                                                    SUBMISSION@OMB.EOP.GOV. Attn:                                               Licensing Opportunity for Ketamine for                                      therapy includes the approved drug,
                                                    Desk Officer for the Administration for                                     the Treatment of Depression and Other                                       ketamine, which has demonstrated
                                                    Children and Families                                                       Anxiety-Related Disorders                                                   robust and acute antidepressant activity.
                                                    Robert Sargis,                                                              AGENCY:        National Institutes of Health,                               However, its efficacy is bridled with
                                                    Reports Clearance Officer.                                                  HHS.                                                                        significant disadvantages including its
                                                                                                                                ACTION:       Notice.                                                       addictive potential and its dissociative
                                                    [FR Doc. 2016–26615 Filed 11–3–16; 8:45 am]
                                                                                                                                                                                                            activities. This is the case even when
                                                    BILLING CODE 4184–01–P
                                                                                                                                SUMMARY:   The National Institute of                                        administered at low doses, which limits
                                                                                                                                Aging (NIA), National Institute of                                          the potential widespread use of
                                                                                                                                Mental Health (NIMH), and National                                          ketamine as an antidepressant
                                                    DEPARTMENT OF HEALTH AND
                                                                                                                                Center for Advancing Translational                                          medication.
                                                    HUMAN SERVICES
                                                                                                                                Sciences (NCATS) of the National                                               In order to improve the treatment of
                                                    Administration for Children and                                             Institutes of Health (NIH), University of                                   depression, it is important to explore
                                                    Families                                                                    Maryland at Baltimore (UMB) and their                                       the mechanism by which ketamine
                                                                                                                                collaborators are seeking Cooperative                                       exerts its antidepressant effects. That is
                                                    Withdrawal of 60-Day Notice of                                              Research and Development Agreement                                          precisely what the NIH and UMB
                                                    Proposed Information Collection:                                            (CRADA) partners to collaborate in the                                      scientists and collaborators are
                                                    Unaccompanied Children Case                                                 preclinical and clinical development of                                     investigating, and have found that the
                                                    Summary Form                                                                ketamine metabolite (2R, 6R-HNK) for                                        metabolism of ketamine is critical to its
                                                                                                                                the treatment of depression and other                                       antidepressant effects, and that the
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                    AGENCY:Administration for Children                                          anxiety-related disorders.                                                  (2R,6R)-2-amino-2-(2-chlorophenyl)-6-
                                                    and Families, HHS.                                                          DATES: Interested candidate partners                                        hydroxycyclohexanone ((2R,6R)-
                                                    ACTION:      Withdrawal: Notice.                                            must submit a statement of interest and                                     hydroxynorketamine (HNK)) metabolite,
                                                                                                                                capability, no more than five pages long,                                   reversed depression-like behaviors in
                                                    SUMMARY:   On October 4, 2016 at 81 FR                                      to the NCATS point of contact before                                        mice without triggering anesthetic,
                                                    68420, ACF published a 60 Day Notice                                        January 3, 2017 for consideration.                                          dissociative, or addictive side effects
                                                    of Proposed Information Collection                                          FOR FURTHER INFORMATION CONTACT:                                            associated with ketamine. Specifically,
                                                    entitled ‘‘Unaccompanied Children Case                                      Information on licensing and co-                                            the researchers found that the


                                               VerDate Sep<11>2014        17:52 Nov 03, 2016          Jkt 241001       PO 00000        Frm 00039        Fmt 4703       Sfmt 4703      E:\FR\FM\04NON1.SGM                04NON1



Document Created: 2018-02-14 08:27:17
Document Modified: 2018-02-14 08:27:17
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionWithdrawal: Notice.
ContactRobert Sargis, Reports Clearance Officer, Office of Planning Research and Evaluation.
FR Citation81 FR 76949 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR